SCHEMBL4964396

SCHEMBL4964396

N#Cc1c(NC(=O)C2CC2c2ccsc2)sc2c1CCNC2

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.46
ALDH1A1 P00352 10/20 0.43
HPGD P15428 4/20 0.43
POLB P06746 3/20 0.43
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2894559 0.87 ALDH1A1 (0.47) MAPK10ALDH1A1HPGDPOLBLMNA
SCHEMBL4961044 0.86 ALDH1A1 (0.48) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4960969 0.84 ALDH1A1 (0.42) MAPK10ALDH1A1HPGDPOLBLMNA
SCHEMBL4960036 0.83 ALDH1A1 (0.43) MAPK10ALDH1A1HPGDPOLBLMNA
SCHEMBL4961200 0.83 ALDH1A1 (0.41) MAPK10ALDH1A1HPGDPOLBLMNA
SCHEMBL2887971 0.83 LMNA (0.48) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4961190 0.83 SMN1; SMN2 (0.48) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4960071 0.83 TP53 (0.43) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4964184 0.81 ALDH1A1 (0.41) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL2891422 0.81 ALDH1A1 (0.47) ALDH1A1HPGDPOLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896484-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-12 EP disclosed
WO-2006125813-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed